Program

Korea Standard Time
Local Time

Daily Program

Updated as of January 31, 2024
It is based on the local time of Seoul, Korea. (UTC+9)



Thursday, June 20


Plenary Lecture 1
Date & Time 6/20(Thu) 10:50-11:30 Room Crystal Ballroom (2F)
Things to consider in designing personalized cancer vaccines
Soonmyung Paik (Yonsei University College of Medicine)

Plenary Lecture 2
Date & Time 6/20(Thu) 11:30-12:10 Room Crystal Ballroom (2F)
Decoding critical targets of the LKB1/STK11 Tumor Suppressor in NSCLC
Reuben Shaw (Salk Institute for Biological Studies, USA)

Special Symposium
Session Title KCA Golden Jubilee and Global Cancer Network
Date & Time 6/20(Thu) 13:30-14:50 Room Crystal Ballroom B (2F)
1) KCA - The half of the 100 years
Tae You Kim (Seoul National University College of Medicine)
2) JCA walking with Asian researchers
Takashi Kohno (National Cancer Center Japan, Japan)
3) CACA's role in National Cancer Control
Ying Wang (China Anti-Cancer Association, China)
4) Building an Asian research network through cancer research in Singapore
Ashok Venkitaraman (National University of Singapore, Singapore)
5) AACR and KCA, united in the fight against cancer
Elizabeth M. Jaffee (Johns Hopkins University School of Medicine, USA)

Educational Sessions 1
Session Title Advanced modeling for predicting and enhancing radiotherapy response
Date & Time 6/20(Thu) 09:00-10:00 Room Crystal Ballroom B (2F)
1) Considerations in constructing radiotherapy-related learning-based predictive models
Hojin Kim (Yonsei University College of Medicine)
2) Next-generation radiotherapy using AI, radiomics, and mechanistic modeling
WonMo Sung (The Catholic University of Korea College of Medicine)
3) Personalizing radiotherapy for locally advanced non-small cell lung cancer
Nitin Ohri (Montefiore Einstein Comprehensive Cancer Center, USA)

Educational Session 2 [KOR]
Session Title Hereditary and early-onset cancers
Date & Time 6/20(Thu) 09:00-10:00 Room Sapphire Ballroom A (3F)
1) Management of hereditary breast and ovarian cancer syndrome - Optimal screening, risk reducing interventions and treatment
Sang-Ah Han (Kyung Hee University School of Medicine)
2) Targeting homologous recombination deficiency and mechanisms of resistance
Koung Jin Suh (Seoul National University Bundang Hospital)
3) Genomic approaches to identify homologous recombination deficiency
Tae-Min Kim (The Catholic University of Korea College of Medicine)

Educational Session 3
Session Title Novel therapeutic targets to regulate tumor microenvironment
Date & Time 6/20(Thu) 15:30-17:10 Room Crystal Ballroom B (2F)
1) Intratumoral regulatory T cells for targeted depletion therapy
Su-Hyung Park (KAIST)
2) Immune regulation by CAFs
Rolf Brekken (UT Southwestern, USA)
3) Nutrition-deprived TME can regulate tumor immunity
Jae-Hoon Chang (Yeungnam University College of Pharmacy)
4) Senescent cancer stromal cells, a major player, not a player in the back seat
Makoto Nakanishi (The University of Tokyo, Japan)

Symposium 01
Session Title Next-generation therapeutics for oncogene-driven cancers
Date & Time 6/20(Thu) 09:00-10:00 Room Crystal Ballroom A (2F)
1) Next-generation treatments for EGFR-mutant cancers
Eun Joo Kang (Korea University College of Medicine)
2) Next-generation HER2-targeted therapy for HER2-amplified cancers
Hee Kyung Ahn (Gachon University College of Medicine)
3) Treatment advances in KRAS G12C mutant cancers
Sae-Won Han (Seoul National University College of Medicine)

Symposium 02
Joint Symposium of KCA & China Anti-Cancer Association (CACA)
Session Title Preventing and monitoring Asian cancers
Date & Time 6/20(Thu) 13:30-15:10 Room Crystal Ballroom A (2F)
1) Environmental risk factors and cancer in Asia
Kyoung-Nam Kim (Yonsei University College of Medicine)
2) Cancer screening in China: Current evidence and future challenge
Kexin Chen (Tianjin Medical University Cancer Institute & Hospital, China)
3) Personalized cancer prevention : Asian perspectives
Daehee Kang (Seoul National University College of Medicine)
4) Primary prevention of gastric cancer in a high-risk area of China
Wen-Qing Li (Peking University Cancer Hospital, China)

Symposium 03
Session Title Early cancer detection and cancer prevention in the molecular era
Date & Time 6/20(Thu) 13:30-15:10 Room Sapphire Ballroom A (3F)
1) Predisposition genes & genetic testing in cancer
Sun-Young Kong (National Cancer Center)
2) Family history of cancer as a proxy marker of aggregation of the genetic factors
Boyoung Park (Hanyang University College of Medicine)
3) Noninvasive molecular testing for cancer screening and diagnosis
Jee-Soo Lee (Seoul National University College of Medicine)
4) Lung cancer screening in Asia
Pan-Chyr Yang (National Taiwan University College of Medicine, Taiwan)

Symposium 04
Session Title Oligometastasis
Date & Time 6/20(Thu) 13:30-15:10 Room Belle-Vue (36F)
1) Suggestion of simpler classification of oligometastases based on systematic review
Chai Hong Rim (Korea University College of Medicine)
2) SABR for oligometastatic cancer: Practical considerations
Kyung Hwan Kim (Yonsei University College of Medicine)
3) Oligometastasis: In the era of systemic targeted and immunotherapy
Jang Ho Cho (The Catholic University of Korea College of Medicine)
4) Oligoprogression: past, present, and future
Sarah Baker (University of British Columbia, Canada)

Symposium 05
Joint Symposium of KCA & Japanese Cancer Association (JCA)
Session Title Next-generation precision oncology
Date & Time 6/20(Thu) 15:30-17:10 Room Crystal Ballroom A (2F)
1) Unlocking insights: The legacy of K-MASTER in cancer research
Yoon Ji Choi (Korea University College of Medicine)
2) Real-world evidence generated from C-CAT’s big data
Takashi Kohno (National Cancer Center Japan, Japan)
3) New perspectives on clinical application of NGS/WGS in Korea
Jeonghwan Youk (Seoul National University College of Medicine)
4) Clinical significance of whole genome sequencing in pediatric cancer
Motohiro Kato (The University of Tokyo, Japan)

Symposium 06
Joint Symposium of KCA & Korean Society of Pediatric Hematology-Oncology (KSPHO)
Session Title Recent update in pediatric-type sarcoma
Date & Time 6/20(Thu) 15:30-17:10 Room Sapphire Ballroom A (3F)
1) Update on molecular pathology of pediatric-type sarcoma
Jung-Sun Kim (Sungkyunkwan University School of Medicine)
2) New technology in surgical management of pediatric bone tumor
Han-Soo Kim (Seoul National University College of Medicine)
3) Updates on the management of pediatric-type sarcoma
Jun Ah Lee (National Cancer Center)
4) Update on radiotherapy for pediatric-type sarcoma
Seo Hee Choi (Yonsei University College of Medicine)

Symposium 07 [KOR]
Session Title Informatics in oncology 2024
Date & Time 6/20(Thu) 15:30-17:10 Room Belle-Vue (36F)
1) Integrated proteogenomic characterization of glioblastoma evolution
Jong Bae Park (National Cancer Center Graduate School of Cancer Science and Policy)
2) National Bio Big Data Project for precision medicine
Eun-Hye Shim (Ministry of Health and Welfare)
3) Federated learning based data analytics platform for precision medicine
Hee Hwang (Kakao Healthcare)
4) Health providers’ property right to electronic health records
Wonbok Lee (Ewha Womans University)

Industry Corner
Session Title KCA-industry collaboration for future cancer research - New modalities in cancer drug development
Date & Time 6/20(Thu) 13:30-15:10 Room Sapphire Ballroom B (3F)
1) Leveraging AI in precision medicine and drug discovery through Vertical LLM
Jaewoo Kang (Korea University/AIGEN Sciences)
2) Harnessing T cell receptors to fight against EGFR mutant lung cancer
Byoung Chul Cho (Yonsei University College of Medicine)
3) Precise ADC(Antibody Drug Conjugate) discovery along the bedside
Do-Hyun Nam (Samsung Medical Center/AimedBio)
4) Commensal gut microbiota promotes antitumor immunity through activation of iron-sequestration in tumor infiltrating macrophages
Garima Sharma (ImmunoBiome)

Luncheon Symposium 1 (Boryung)
Date & Time 6/20(Thu) 12:20-13:00 Place Crystal Ballroom A (2F)
SCLC: New treatment paradigms and a glimpse into our treatment options of tomorrow
Jii Bum Lee (Yonsei University College of Medicine)

Satellite Symposium 1 (Astellas)
Date & Time 6/20(Thu) 09:00-09:40 Place Sapphire Ballroom B (3F)
CLDN18.2 targeting treatment for gastric cancer
Hyung-Don Kim (University of Ulsan College of Medicine)

Satellite Symposium 2 (Boryung)
Date & Time 6/20(Thu) 15:30-16:10 Place Sapphire Ballroom B (3F)
Pancreatic cancer: State-of-the-Art Neo/Adjuvant treatment in pancreatic cancer_ Guidance for oncologist
Chung Ryul Oh (Chung-Ang University Hospital)


International Session 1
Date & Time 6/20(Thu) 13:30-15:00 Room Sapphire Ballroom C (3F)
1) Intraperitoneal paclitaxel plus systemic FOLFOX for gastric cancer with peritoneal metastasis - results of the IPLUS phase II trial
So Hyun Kang (Seoul National University Bundang Hospital)
2) Transcriptome-wide association study identifies genetic predisposition for risk stratification of gastric cancer and effect modification of helicobacter pylori treatment
Zhouyi Yin (Peking University Cancer Hospital & Institute, China)
3) Tumoral IL-33/ST2 signaling drives immune escape through reduced antigen presentation
Kevin Van der Jeught (University of Miami Miller School of Medicine, USA)
4) Preliminary clinical results of a therapeutic cancer vaccine PDC*lung01 in combination with anti-PD-1 in patients (pts) with stage IV NSCLC
Felicia Kim (PDC*line Pharma SA, Belgium)
5) Impact of intestinal microbiome on the efficacy of immune checkpoint inhibitors and anti-tumor immunity in patients with non-small cell lung cancer
Jin-Soo Kim (Seoul National University Boramae Medical Center)
6) Risk assessment of incident lung cancer in never smokers with a family history of lung cancer: A Kangbuk Samsung cohort study
Yun-Gyoo Lee (Kangbuk Samsung Hospital)


Oral Presentation [KOR]
Date & Time 6/20(Thu) 15:30-17:15 Room Sapphire Ballroom C (3F)
1) Stemness subtype gastric cancer accelerate hematogenous metastasis
Jaeun Yoo (Seoul National University)
2) RNA expression of 6 genes from metastatic mucosal gastric cancer serves as the global prognostic marker for gastric cancer with functional validation
Jieun Lee (Seoul National University Bundang Hospital)
3) Spatial radiogenomics analysis reveals intratumor heterogeneity in heteroechoic breast cancer
Jiyun Hong (Yonsei University College of Medicine)
4) Patient-reported outcomes in N1 breast cancer: a phase III trial comparing whole-breast to whole-breast plus regional irradiation after taxane-based chemotherapy (KROG 17-01)
Nalee Kim (Samsung Medical Center)
5) SMAD4, TP53 and mutually-exclusive mutations predicts FOLFIRINOX and Gem/nab-paclitaxel sensitivity in pancreatic ductal adenocarcinoma
Eunwoo Choi (Yonsei University College of Medicine)
6) Comprehensive analysis for microvascular invasion in hepatocellular carcinoma reveals underlying biology to build precision medicine
Woo Young Kwon (CHA Future Medicine Research Institute, CHA University)
7) Genomic classification of intrapulmonary metastasis and multiple primary lung cancer
Jeongsoo Won (Yonsei University College of Medicine)


Friday, June 21


Plenary Lecture 3 [KOR]
Date & Time 6/21(Fri) 11:00-11:40 Room Crystal Ballroom (2F)
Evolution of cancer treatment and development of Korean Cancer Association
Yung-Jue Bang (Seoul National University College of Medicine)

Plenary Lecture 4
Date & Time 6/21(Fri) 11:40-12:20 Room Crystal Ballroom (2F)
How whole genome sequencing can advance precision medicine
Emile Voest (Netherlands Cancer Institute, Netherlands)

Educational Session 4
Session Title Artificial intelligence for clinical data and big laboratory data
Date & Time 6/21(Fri) 09:00-10:40 Room Crystal Ballroom B (2F)
1) A system development methodology using protein 3D structure prediction in the field of biomedicine
Dongwan Hong (The Catholic University of Korea College of Medicine)
2) Machine leaning on cancer genome and immune data can predict chemotherapy response of upper GI cancers
Hidewaki Nakagawa (RIKEN Center for Integrative Medical Sciences, Japan)
3) AI using multiple clinical & imaging data for cancer research
Kyu-Hwan Jung (Samsung Advanced Institute for Health Sciences & Technology)
4) Advancing medical imaging research and Artificial Intelligence through standardization
Soon Ho Yoon (Seoul National University College of Medicine)

Educational Session 5
Session Title Evolution of the WHO classifications of tumors in the molecular era
Date & Time 6/21(Fri) 09:00-10:40 Room Sapphire Ballroom A (3F)
1) Evolution of the WHO classifications of CNS tumors in the molecular era
Se Hoon Kim (Yonsei University College of Medicine)
2) Evolving role of genomic testing in malignant lymphoma
Yoon Kyung Jeon (Seoul National University College of Medicine)
3) Breast tumors - WHO classification and evolving perspectives
Puay Hoon Tan (Luma Medical Centre, Singapore)
4) Tumors of the gastrointestinal tracts
Kyoung-Mee Kim (Sungkyunkwan University School of Medicine)

Educational Session 6 [KOR]
Session Title Perioperative MDT approach for advanced cancer
Date & Time 6/21(Fri) 14:30-16:10 Room Sapphire Ballroom B (3F)
1) Pathology insights in MDT: Driving precision diagnostics and treatment in cancer care
Hye Seung Lee (Seoul National University College of Medicine)
2) The vital importance of the multidisciplinary team win managing lung cancer: A thoracic surgeon’s view
Chang Young Lee (Yonsei University College of Medicine)
3) Navigating the cancer journey: The integral role of medical oncology in MDT strategies
Sehhoon Park (Samsung Medical Center)
4) Targeting cancer with precision: The integral role of radiation oncology in MDT strategies
Sung Uk Lee (National Cancer Center)

Educational Session 7
Session Title Treatment approach through tracking ctDNA
Date & Time 6/21(Fri) 16:30-17:30 Room Crystal Ballroom A (2F)
1) Tumor informed vs. tumor agnostic ctDNA analysis
Seung-Tae Lee (Yonsei University College of Medicine)
2) A new era of molecular residual disease: Optimizing perioperative chemotherapy for colorectal cancer
Eiji Oki (Kyushu University, Japan)
3) ctDNA monitoring in metastatic cancer
Wonyoung Choi (National Cancer Center)

Symposium 08
Joint Symposium of KCA & Korean Association of Immunologists (KAI)
Session Title Next-generation antibody and cellular therapies in immuno-oncology
Date & Time 6/21(Fri) 09:00-10:40 Room Crystal Ballroom A (2F)
1) Preclinical study of biparatopic ADC targeting MET to overcome acquired resistance to EGFR TKI in EGFR-mutant NSCLC
Sun Min Lim (Yonsei University College of Medicine)
2) Next-generation antibody development for cancer therapy
Ho Min Kim (KAIST)
3) Engineering next generation T cell therapy for cancer
Chan Hyuk Kim (Seoul National University School of Transdisciplinary Innovations)
4) Transcriptional & epigenetic engineering for immune cell therapy of solid tumours
Hyungseok Seo (Seoul National University College of Pharmacy)

Symposium 09
Joint Symposium of KCA & Cancer Science Institute of Singapore (CSI Singapore)
Session Title Understanding and targeting genomic instability
Date & Time 6/21(Fri) 14:30-16:10 Room Crystal Ballroom A (2F)
1) Whole-genome sequencing reveals the homologous recombination deficiency in human cancer
Young Seok Ju (KAIST)
2) Metabolic triggers for cancer genome evolution
Ashok Venkitaraman (National University of Singapore, Singapore)
3) In vivo CRISPR therapy targeting cancer-specific genetic alterations
Taejoon Kwon (UNIST)
4) Targeting DNA damage repair deficiency in gynaecological cancers
David SP Tan (National University of Singapore, Singapore)

Symposium 10
Joint Symposium of KCA & Korea Genome Organization (KOGO)
Session Title Functional genomics for novel targets
Date & Time 6/21(Fri) 14:30-16:10 Room Sapphire Ballroom A (3F)
1) Proteogenomic characterization reveals estrogen signaling as a target for never-smoker lung adenocarcinoma patients without EGFR or ALK alterations
Seon-Young Kim (Korea Research Institute of Bioscience and Biotechnology)
2) Emerging therapeutic targets for systemic treatment of advanced gastric cancer
In-Ho Kim (The Catholic University of Korea College of Medicine)
3) Single cell-based target identification in cancers
Jihwan Park (GIST)
4) Dissecting heterogeneity of histologic patterns reveals a novel target of lung adenocarcinoma
Shin Yup Lee (Kyungpook National University School of Medicine)

Symposium 11 [KOR]
Session Title 국가암진료 가이드라인 사업 성과와 발전 방안
Date & Time 6/21(Fri) 14:30-16:10 Room Belle-Vue (36F)
1) 암진료가이드라인 사업 추진 현황
곽호신 (국립암센터)
2) 암진료가이드라인 개발 방법론과 검수사항
김수영 (한림의대)
3) 위암 진료 가이드라인 소개
한혜숙 (충북의대)
4) 갑상선암 진료 가이드라인 소개
이은경 (국립암센터)
5) 결장암 진료 가이드라인 소개
곽정면 (고려의대)

Overseas Korean Researcher Session
Date & Time 6/21(Fri) 14:30-15:45 Room Crystal Ballroom B (2F)
1) Role of vascular functions in cancer treatment
Chang Won Song (University of Minnesota, USA)
2) Vascular regulation of tumor immune exclusion and progression
Minah Kim (Columbia University, USA)
3) Hypoxia as a regulator of tumor stroma
Kyoung Eun Lee (University of Michigan, USA)

Young Investigator Symposium
Date & Time 6/21(Fri) 16:30-17:30 Room Crystal Ballroom B (2F)
1) Mechanisms of oncogenic tyrosine kinase fusion selection in human cancer
Taek-Chin Cheong (Boston Children's Hospital and Harvard Medical School, USA)
2) Multi-paratopic decoy receptor PD-L1 Grab synergizes with chemotherapy by targeting CD141+ cancer-associated fibroblasts in pancreatic cancer
Duk Ki Kim (Chungnam National University Hospital)
3) Immunotherapy for pancreatic cancer: DNA damage repair deficiency and beyond
Wungki Park (Memorial Sloan Kettering Cancer Center, USA)

Luncheon Symposium 2 (MSD)
Date & Time 6/21(Fri) 12:30-13:10 Place Crystal Ballroom A (2F)
Unlocking the door: A paradigm shift in early-stage NSCLC treatment with pembrolizumab
Se-Hoon Lee (Sungkyunkwan University School of Medicine)

Satellite Symposium 3 (MSD)
Date & Time 6/21(Fri) 09:00-09:20 Place Sapphire Ballroom B (3F)
A first-line treatment option for locally advanced unresectable or metastatic biliary track cancer
Jaekyung Cheon (University of Ulsan College of Medicine)

Satellite Symposium 4 (Lilly)
Date & Time 6/21(Fri) 09:20-10:00 Place Sapphire Ballroom B (3F)
A journey to the hope of HR+/HER2- EBC&MBC patient: Abemaciclib new data
Jieun Lee (The Catholic University of Korea College of Medicine)


International Session 2
Date & Time 6/21(Fri) 09:00-10:45 Room Sapphire Ballroom C (3F)
1) Pan-cancer alternative transcription analysis with ArtistR: A machine learning method reveals novel cancer-related alternative transcript initiation in a transcript-agnostic way
Hyo Young Choi (University of Tennessee, USA)
2) Pelvic ultrasound-based deep learning models for accurate diagnosis of ovarian cancer: Retrospective multicenter study
Hyun-Woong Cho (Korea University Guro Hospital)
3) Tumoroid’s Multi-Parameter (TMP) model for predicting recurrence in ovarian cancer patients receiving first- and second-line chemotherapy
Dong Woo Lee (Gachon University)
4) Efficacy and safety of intravenous administration of high-dose selenium for preventing chemotherapy-induced peripheral neuropathy in platinum-sensitive recurrent ovarian cancer: A double blind, randomized placebo-controlled trial
Hee Seung Kim (Seoul National University College of Medicine)
5) Efficacy of stereotactic ablative radiotherapy in patients with oligometastatic hepatocellular carcinoma; a phase II study (Clinical Trial Number: NCT05173610)
Jinsil Seong (Yonsei University College of Medicine)
6) Utilization of circulating tumor DNA (ctDNA) for the molecular characterization of IDH1 mutant cholangiocarcinoma
Do-Youn Oh (Seoul National University Hospital, Cancer Research Institute, Seoul National University Hospital College of Medicine)
7) Comprehensive analysis of mutations and clonal evolution patterns in serial liquid biopsy of biliary tract cancer (BTC) patients treated with gemcitabine/cisplatin (gem/cis)
Choong-kun Lee (Yonsei Cancer Center, Yonsei University College of Medicine)

top